https://www.teva.cn/our-products/patient-safety/patient-medication-faqs/2024-02-14T17:16:42+00:00weekly0.5https://www.teva.cn/about-teva/company-profile/2024-02-14T17:21:56+00:00yearly0.5https://www.teva.cn/our-products/teva-and-jiangsu-enhua-pharmaceutical-forge-strategic-partnership-to-promote-patient-access-to-antitan-in-china/2024-03-08T08:05:12+00:00monthly0.5https://www.teva.cn/about-teva/our-history/2024-02-14T17:21:32+00:00yearly0.5https://www.teva.cn/about-teva/code-of-conduct/2024-02-14T17:20:44+00:00yearly0.5https://www.teva.cn/about-teva/our-values/2024-02-14T17:19:31+00:00yearly0.5https://www.teva.cn/about-teva/facts-and-figures/2024-02-14T17:19:04+00:00yearly0.5https://www.teva.cn/our-products/patient-safety/2024-02-14T17:16:02+00:00yearly0.5https://www.teva.cn/our-products/specialty/2024-02-14T17:17:11+00:00yearly0.5https://www.teva.cn/our-products/taking-advantage-of-dongfeng-innovative-migraine-drug/2024-02-14T17:15:06+00:00monthly0.5https://www.teva.cn/our-products/teva-and-yurui-jointly-announced-the-listing-of-cunda/2024-02-14T17:17:40+00:00yearly0.5https://www.teva.cn/about-teva/2024-02-14T17:18:34+00:00yearly0.5https://www.teva.cn/our-products/2024-02-14T17:14:07+00:00yearly0.5https://www.teva.cn/phv-privacy-policy/2024-12-11T09:52:14+00:00monthly0.5https://www.teva.cn/terms-of-use/2024-02-14T17:25:17+00:00yearly0.5https://www.teva.cn/error-500/2024-02-14T17:22:53+00:00yearly0.5https://www.teva.cn/error-404-page/2024-02-14T17:22:33+00:00yearly0.5https://www.teva.cn/accessibility/2024-02-14T17:23:25+00:00yearly0.5https://www.teva.cn/search-result/2024-02-14T17:25:46+00:00yearly0.5https://www.teva.cn/contact-us/2024-02-14T17:26:11+00:00yearly0.5https://www.teva.cn/privacy-policy/2024-02-14T17:24:39+00:00yearly0.5https://www.teva.cn/2026-02-12T07:38:26+00:00monthly0.5